Black Swan Pharmaceuticals
Focus: Black Swan Pharmaceuticals is a publicly listed biotech company focused on antisense RNA-based therapeutics for amyotrophic lateral sclerosis (ALS) and related neurological conditions. Founded in 2021 and headquartered in Wake Forest, NC, the company operates in the specialized gene therapy space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Black Swan Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Black Swan Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
0/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Clinical follow-up 1
Monoclonal Gammopathy of Undetermined SignificanceOpen Jobs (0)
No open positions listed yet.
Interview Prep Quick Facts
Help build intelligence for Black Swan Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.